Response to nivolumab in metastatic collecting duct carcinoma expressing PD-L1: A case report

The authors present a case report of collecting duct carcinoma (CDC) that responded to nivolumab, a programmed death 1 (PD-1) immune-checkpoint-inhibitor antibody, following the failure of systemic treatment with chemotherapy and targeted therapy. The patient underwent right radical nephrectomy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizutani, Kosuke, Horie, Kengo, Nagai, Shingo, Tsuchiya, Tomohiro, Saigo, Chiemi, Kobayashi, Kazuhiro, Miyazaki, Tatsuhiko, Deguchi, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740828/
https://www.ncbi.nlm.nih.gov/pubmed/29285361
http://dx.doi.org/10.3892/mco.2017.1449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740828/
https://www.ncbi.nlm.nih.gov/pubmed/29285361
http://dx.doi.org/10.3892/mco.2017.1449

Ejemplares similares